MFDS — authorised 28 February 2001
- Marketing authorisation holder: JANSSEN PHARMS
- Status: likely_approved
🇰🇷 Razadyne in South Korea
MFDS authorised Razadyne on 28 February 2001
Marketing authorisation
Razadyne in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in South Korea
Frequently asked questions
Is Razadyne approved in South Korea?
Yes. MFDS authorised it on 28 February 2001.
Who is the marketing authorisation holder for Razadyne in South Korea?
JANSSEN PHARMS holds the South Korean marketing authorisation.